Blog

One-on-One with BBK's Director of
Tech Experience Dena Raffa 

There's no question that digital technology is changing the way we engage with patients and altering expectations for the patient experience. As part of our Pharma15 Live! series, we sat down with BBK's Director of Tech Experience Dena Raffa to get her perspective on current trends.

Raffa has been instrumental in many of BBK's software solutions and digital technologies, and most recently she has led the development of BBK's new patient engagement portal - a first of its kind for clinical trial participants.

Creating a Patient- and Site-Centric Environment for Decentralized Clinical Trials

Hear from the Experts! 

As decentralized clinical trials reshape the clinical research landscape, Chief Innovation Officer Rob Laurens and Lead Concierge Alex Nicholl discuss efforts to help study sponsors embrace these trials with ease and confidence.

Meaningful Engagement at Critical Touchpoints along the Patient Journey

There's no better way to illustrate the importance of meaningful engagement than with the story of one family's journey from clinical trial awareness to participation. The story shows how the right mix of digital and physical touchpoints plays a critical role in creating a positive patient experience. The family's journey begins below.

New eBook Available for Download

As we continue to focus our attention on underserved populations, we've just released a content-rich eBook full of guidance that study sponsors can leverage to create a more diverse and inclusive clinical trial environment. It features a bonus section with excerpts from our recent Q&A with Michele Russell-Einhorn, chief compliance officer and institutional official at Advarra, that provide an IRB's perspective on improving diversity and inclusion in clinical trials.

Earlier this week, BBK Principal Rob Laurens went one-on-one with Outsourcing-Pharma discussing the launch of BBK's Engagement Solution Center for decentralized and post-marketing clinical trials, which features concierge service delivery and a robust patient experience portal to ease the clinical trial journey.

In this in-depth interview, Rob addresses the importance and advantages of centralizing design, management, operations, and communications of patient support services. In addition, he provides insight into some of the conversations that led to the creation of the center. Click here to read the full article.

Improving Diversity and Inclusion in Clinical Trials

One-on-One with Advarra

Get an IRB's perspective on improving diversity and inclusion in clinical trials by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official at Advarra.

PHARMA15 LIVE!

How Do Patients Feel About Hybrid
and Decentralized Clinical Trials?

What Are Must-Haves for
a Positive Patient Experience?

Patient advocates take center stage in this Pharma15 Live! overtime segment and share their thoughts on hybrid and decentralized clinical trials.

Moderated by BBK Worldwide Founding Principal Bonnie A. Brescia, this segment continues the conversation from a Patients as Partners Europe panel and answers questions asked by study sponsors in attendance.

Strategies to Help Improve Clinical Trial Diversity and Inclusion

From Engaging Locally to Removing Financial Obstacles

With health equity at the forefront of many conversations today, study sponsors are seeking ways to make clinical trial participation more inclusive.

At BBK Worldwide, we believe that clinical trials for investigational treatments should reflect the populations that could benefit from them, with the long-term goal of achieving better health interventions for those in greatest need. To help facilitate participation of underserved populations, we have outlined strategic guidance that study sponsors can leverage in their efforts.

Sharing in the commitment to advance research and knowledge for the Parkinson’s disease community, BBK Worldwide is proud to support the 2021 Parkinson’s Disease Therapeutics Webinar Series, hosted by The Michael J. Fox Foundation.

This free online series brings together Parkinson’s researchers, drug developers, and clinicians to discuss new findings and trending topics in Parkinson’s research and development.

BBK Worldwide Featured in Newly Published Innovations in Pharmaceutical Development™

Guide Provides In-Depth Profiles of World’s Most Disruptive Pharma Services Innovators

BBK Worldwide has been recognized as a top innovator in Innovations in Pharmaceutical Development™. This newly published guide highlights the companies and thought leaders at the forefront of innovation in the pharmaceutical development space.